Novel Federated Decision Making for Distribution of Anti-SARS-CoV-2 Monoclonal Antibody to Eligible High-Risk Patients

Novel Federated Decision Making for Distribution of Anti-SARS-CoV-2 Monoclonal Antibody to Eligible High-Risk Patients

Context: When the epidemic ¯rst broke out, no speci¯c treatment was available for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The urgent need to end this unusual sit uation has resulted in many attempts to deal with SARS-CoV-2. In addition to several types of vaccinations that have...

Full description

Saved in:
Bibliographic Details
Main Author: AlSereidi, Abeer (author)
Other Authors: Qahtan M. Salih, Sarah (author), Mohammed, R. T. (author), A. Zaidan, A. (author), Albayati, Hassan (author), Pamucar, Dragan (author), Albahri, A. S. (author), Zaidan, B. B. (author), Shaalan, Khaled (author), Al-Obaidi, Jameel (author), Albahri, O. S. (author), Alamoodi, Abdulah (author), Abdul Majid, Nazia (author), Garfan, Salem (author), Al-Samarraay, M. S. (author), Jasim, A. N. (author), Baqer, M. J. (author)
Published: 2022
Subjects:
Anti-SARS-CoV-2; monoclonal antibodies; MCDM; FWZIC; TOPSIS.
Online Access:https://bspace.buid.ac.ae/handle/1234/2782
https://doi.org/10.1142/S021962202250050X.
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items